Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | DNA topoisomerase II, putative | 0.0127 | 0.1238 | 1 |
Entamoeba histolytica | phospholipase D, putative | 0.0107 | 0.0907 | 0.4563 |
Loa Loa (eye worm) | TOPoisomerase family member | 0.0127 | 0.1238 | 0.1238 |
Plasmodium falciparum | DNA gyrase subunit B | 0.0545 | 0.8022 | 1 |
Onchocerca volvulus | DNA topoisomerase 2 homolog | 0.0127 | 0.1238 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.0629 | 0.0629 |
Echinococcus granulosus | DNA topoisomerase 2 alpha | 0.0127 | 0.1238 | 0.0575 |
Mycobacterium leprae | Probable DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (Type II DNA topoisomerase) | 0.0188 | 0.2217 | 0.5 |
Echinococcus multilocularis | geminin | 0.0357 | 0.4974 | 0.4594 |
Schistosoma mansoni | hypothetical protein | 0.0357 | 0.4974 | 0.4974 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0315 | 0.4286 | 1 |
Brugia malayi | Probable DNA topoisomerase II | 0.0127 | 0.1238 | 0.0365 |
Echinococcus granulosus | indoleamine 23 dioxygenase 2 | 0.0667 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0.0301 | 0.0301 |
Brugia malayi | DNA gyrase/topoisomerase IV, A subunit family protein | 0.0127 | 0.1238 | 0.0365 |
Echinococcus multilocularis | indoleamine 2,3 dioxygenase 2 | 0.0667 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | DNA gyrase, topoisomerase II, B subunit, GyrB | 0.0545 | 0.8022 | 0.5 |
Plasmodium vivax | DNA gyrase subunit B, putative | 0.0545 | 0.8022 | 1 |
Schistosoma mansoni | DNA topoisomerase II | 0.0127 | 0.1238 | 0.1238 |
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0.0301 | 0.0301 |
Chlamydia trachomatis | DNA gyrase subunit B | 0.0545 | 0.8022 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0667 | 1 | 1 |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0315 | 0.4286 | 1 |
Giardia lamblia | DNA topoisomerase II | 0.011 | 0.096 | 0.5 |
Loa Loa (eye worm) | indoleamine 2,3-dioxygenase | 0.0667 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0667 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0357 | 0.4974 | 0.4974 |
Treponema pallidum | DNA gyrase, subunit B (gyrB) | 0.0545 | 0.8022 | 0.5 |
Schistosoma mansoni | phospholipase D | 0.0107 | 0.0907 | 0.0907 |
Entamoeba histolytica | phospholipase D, putative | 0.0107 | 0.0907 | 0.4563 |
Onchocerca volvulus | Putative DNA topoisomerase 2, mitochondrial | 0.0127 | 0.1238 | 1 |
Echinococcus multilocularis | phospholipase D1 | 0.0107 | 0.0907 | 0.0218 |
Trypanosoma brucei | DNA topoisomerase ii | 0.0315 | 0.4286 | 1 |
Echinococcus granulosus | phospholipase D1 | 0.0107 | 0.0907 | 0.0218 |
Trichomonas vaginalis | DNA topoisomerase II, putative | 0.0127 | 0.1238 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0088 | 0.0605 | 0.0605 |
Onchocerca volvulus | DNA topoisomerase 2 homolog | 0.0127 | 0.1238 | 1 |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0315 | 0.4286 | 1 |
Mycobacterium ulcerans | DNA gyrase subunit B | 0.0545 | 0.8022 | 0.5 |
Echinococcus granulosus | tumor protein p63 | 0.0349 | 0.4843 | 0.4453 |
Echinococcus multilocularis | tumor protein p63 | 0.0349 | 0.4843 | 0.4453 |
Brugia malayi | DNA topoisomerase II, alpha isozyme | 0.0127 | 0.1238 | 0.0365 |
Mycobacterium tuberculosis | DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (type II DNA topoisomerase) | 0.0545 | 0.8022 | 1 |
Leishmania major | mitochondrial DNA topoisomerase II | 0.0315 | 0.4286 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0088 | 0.0605 | 0.0605 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.0629 | 0.0629 |
Echinococcus granulosus | geminin | 0.0357 | 0.4974 | 0.4594 |
Echinococcus multilocularis | DNA topoisomerase 2 alpha | 0.0127 | 0.1238 | 0.0575 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.768 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.526 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.389 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.389 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.341 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.278 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.025 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.